Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Agios Pharm

Agios Pharm

AGIO · NASDAQ
AGIO · NASDAQ

Next Earnings: 30 Jul 2025

33.26
USD-0.26-0.78%

Latest News

    @bitcoinagile
    bitcoinagile

    AGIO D Long Setup for NASDAQ:AGIO by alihikmetharun #AGIO #btc #usdt #Crypto #coin #forex https://t.co/z7EV0Ux7Wi https://t.co/9PYdsrN5eG

    Analysts Recommendations

    Bullish

    Buy

    Strong Buy

    Buy

    Hold

    Sell

    Strong Sell

    Day Range

    33.14USD
    33.88USD

    52 Week Range

    23.41USD
    62.58USD

    Market Cap

    1.71BUSD

    lock-imagelock-image

    Get Full Access with Profit PRO

    See which Billionaires own this investment

    About

    General Information

    Type

    Common Stock

    Exchange

    NASDAQ

    Currency Code

    USD

    Currency Name

    US Dollar

    Country Name

    USA

    Country ISO

    US

    ISIN

    US00847X1046

    CUSIP

    00847X104

    Sector

    Healthcare

    Industry

    Biotechnology

    Fiscal Year End

    December

    IPO date

    -

    Updated At

    -

    Highlights

    PE Ratio

    2.90

    PEG Ratio

    -

    Book Value

    25.33

    Dividend Share

    -

    Dividend Yield

    -

    Earnings Share

    11.54

    Wall Street Target Price

    51.71

    EPS Estimate Current Year

    -7.14

    EPS Estimate Next Year

    -6.30

    EPS Estimate Current Quarter

    -1.76

    EPS Estimate Next Quarter

    -1.8533

    Most Recent Quarter

    -

    Profitability

    Revenue TTM

    37,035,000

    Gross Profit TTM

    -272,996,992

    EBITDA

    -434,711,008

    Profit Margin

    1798.26%

    Return On Assets TTM

    -22.88%

    Return On Equity TTM

    60.26%

    Revenue Per Share TTM

    0.649

    Qtly Revenue Growth YOY

    6.60%

    Diluted Eps TTM

    11.54

    Qtly Earnings Growth YOY

    0.00%

    Valuation

    Trailing PE

    2.90

    Forward PE

    2

    Price Sales TTM

    52.3403

    Price Book MRQ

    1.3226

    Enterprise Value Revenue

    29

    Enterprise Value EBITDA

    -2

    Peers analysis

    • UCB SA
      UCBJFUCB SA

      201.96

      2.08%
    • Alnylam Pharmaceuticals Inc
      ALNYAlnylam Pharmaceuticals Inc

      326.09

      1.06%
    • UCB SA ADR
      UCBJYUCB SA ADR

      99.34

      0.88%
    • Vertex Pharmaceuticals Inc
      VRTXVertex Pharmaceuticals Inc

      443.80

      0.63%
    • Regeneron Pharmaceuticals Inc
      REGNRegeneron Pharmaceuticals Inc

      524.00

      0.61%
    • Be
      ONCBeiGene, Ltd.

      242.09

      0.57%
    • argenx SE
      ARGNFargenx SE

      569.19

      0.00%
    • CSL Limited
      CMXHFCSL Limited

      153.01

      -3.04%
    • CSL Ltd
      CSLLYCSL Ltd

      77.06

      -2.96%
    • argenx NV ADR
      ARGXargenx NV ADR

      551.55

      -1.45%
    XM

    Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

    Trade with a Trusted, Award-Winning Broker.

    Trading involves risk. The value of investments may go up or down. Trade responsibly.

    FAQs

    What is Agios Pharm stock price today?

    What is Agios Pharm stock ticker?

    Is AGIO stock price going up?

    What is the analyst recommendation for AGIO?

    What is AGIO market cap?

    Does AGIO release financial reports?

    When is AGIO next earnings date?

    What were AGIO Earnings for the last quarter?

    What was AGIO Revenue for the last quarter?

    What was AGIO Net Income for the last quarter?

    Does AGIO pay dividends?

    How many employees does AGIO have?

    What is AGIO EBITDA?

    How to buy AGIO stocks?

    Should I invest in AGIO stock?